Yakun Yi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yakun Yi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hai-Chen Wu
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China
4 shared publications Ke Zhou
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China
3 shared publications- Lei Liu
College of Food and Bioengineering, Xihua University, Chengdu, China
3 shared publications Mingqian Zhang
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China
2 shared publicationsQianyuan Ren
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China
2 shared publications- Wenying Hao
Beijing National Laboratory for Molecular Sciences Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry Chinese Academy of Sciences Beijing China
2 shared publications
Latest Publications
- 9 September 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (11) , 1633
Author Correction: Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism
- 9 September 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (11) , 1633
Author Correction: Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism
- 1 September 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (11) , 1613-1622
Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism
- 1 September 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (11) , 1613-1622
Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism
- Open Access
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
Site-specific post-translational modification detection by polar charged engineered MspA nanopores
Deciphering the complex chemical code of post-translational modifications (PTMs) is fundamental to proteomics but remains challenging due to the low abundance of modified proteins and the difficulty in resolving isobaric positional isomers. Conventional mass spectrometry and affinity-based methods often lack the sensitivity or specificity required to capture this full chemical diversity. Here, we present a general strategy for site-specific PTM recognition based on MspA nanopores engineered with polar charged residues. By systematically tuning the constriction site (position N91) with polar charged residues, we introduced specific electrostatic, electroosmotic flow and steric interactions that dramatically enhance molecular recognition capabilities. This engineered interface enabled the label-free discrimination of 10 distinct PTM types across 26 peptides, including phosphorylation, glycosylation, and—reported here for the first time via nanopore sensing—lysine crotonylation and succinylation. Furthermore, the nanopore is capable of distinguishing subtle positional isomers. Coupled with a machine learning algorithm that classifies single-molecule events with >98% accuracy, our findings establish a generalizable principle of electrostatic gating for PTM profiling, offering a versatile chemical tool for next-generation single-molecule proteomics.
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
Open AccessSite-specific post-translational modification detection by polar charged engineered MspA nanopores
Deciphering the complex chemical code of post-translational modifications (PTMs) is fundamental to proteomics but remains challenging due to the low abundance of modified proteins and the difficulty in resolving isobaric positional isomers. Conventional mass spectrometry and affinity-based methods often lack the sensitivity or specificity required to capture this full chemical diversity. Here, we present a general strategy for site-specific PTM recognition based on MspA nanopores engineered with polar charged residues. By systematically tuning the constriction site (position N91) with polar charged residues, we introduced specific electrostatic, electroosmotic flow and steric interactions that dramatically enhance molecular recognition capabilities. This engineered interface enabled the label-free discrimination of 10 distinct PTM types across 26 peptides, including phosphorylation, glycosylation, and—reported here for the first time via nanopore sensing—lysine crotonylation and succinylation. Furthermore, the nanopore is capable of distinguishing subtle positional isomers. Coupled with a machine learning algorithm that classifies single-molecule events with >98% accuracy, our findings establish a generalizable principle of electrostatic gating for PTM profiling, offering a versatile chemical tool for next-generation single-molecule proteomics.
- 17 April 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (11) , 3298-3304
A nanopore-based enzyme-assisted biomarker detection method for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is frequently complicated by pulmonary hypertension (PH), yet early diagnosis remains challenging due to overlapping clinical features and limited detection sensitivity. Herein, we present a nanopore-based enzyme-assisted biomarker detection method for the simultaneous analysis of microRNA and protein biomarkers, enabling enhanced diagnostic capability of COPD and COPD-associated PH. In this strategy, miR-150-5p serves as an indicator of COPD onset, while vascular endothelial growth factor (VEGF165) reflects pulmonary vascular remodeling and PH progression. By coupling enzyme-assisted signal transduction with α-hemolysin nanopore sensing, conventional immunoassay signals are converted into characteristic ionic current signatures with single-molecule sensitivity. The assay achieves detection limits of 10.0 fM for miR-150-5p and 10.0 fg/mL for VEGF165. This work establishes a unified and highly sensitive platform for dual-biomarker detection, offering a promising approach for early diagnosis and precise evaluation of COPD and its complications
- 17 April 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (11) , 3298-3304
A nanopore-based enzyme-assisted biomarker detection method for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is frequently complicated by pulmonary hypertension (PH), yet early diagnosis remains challenging due to overlapping clinical features and limited detection sensitivity. Herein, we present a nanopore-based enzyme-assisted biomarker detection method for the simultaneous analysis of microRNA and protein biomarkers, enabling enhanced diagnostic capability of COPD and COPD-associated PH. In this strategy, miR-150-5p serves as an indicator of COPD onset, while vascular endothelial growth factor (VEGF165) reflects pulmonary vascular remodeling and PH progression. By coupling enzyme-assisted signal transduction with α-hemolysin nanopore sensing, conventional immunoassay signals are converted into characteristic ionic current signatures with single-molecule sensitivity. The assay achieves detection limits of 10.0 fM for miR-150-5p and 10.0 fg/mL for VEGF165. This work establishes a unified and highly sensitive platform for dual-biomarker detection, offering a promising approach for early diagnosis and precise evaluation of COPD and its complications
- Top Cited Papers
- 14 May 2025
- Published by Springer Nature in Nature Nanotechnology
- Vol. 20 (8) , 1079-1086
Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection
Enzyme-linked immunosorbent assay (ELISA) has been widely used in cancer diagnostics due to its specificity, sensitivity and high throughput. However, conventional ELISA is semiquantitative and has an insufficiently low detection limit for applications requiring ultrahigh sensitivity. In this study, we developed an α-hemolysin-nanopore-based ELISA for detecting cancer biomarkers. After forming the immuno-sandwich complex, peptide probes carrying enzymatic cleavage sites are introduced, where they interact with enzymes conjugated to the detection antibodies within the complex. These probes generate distinct current signatures when translocated through the nanopore after enzymatic cleavage, enabling precise biomarker quantification. This approach offers a low detection limit of up to 0.03 fg ml–1 and the simultaneous detection of six biomarkers, including antigen and antibody biomarkers in blood samples. Overall, the nanopore-based ELISA demonstrates high sensitivity and multiplexing capability, making it suitable for next-generation diagnostic and point-of-care testing applications.
- 14 May 2025
- Published by Springer Nature in Nature Nanotechnology
- Vol. 20 (8) , 1079-1086
Top Cited PapersNanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection
Enzyme-linked immunosorbent assay (ELISA) has been widely used in cancer diagnostics due to its specificity, sensitivity and high throughput. However, conventional ELISA is semiquantitative and has an insufficiently low detection limit for applications requiring ultrahigh sensitivity. In this study, we developed an α-hemolysin-nanopore-based ELISA for detecting cancer biomarkers. After forming the immuno-sandwich complex, peptide probes carrying enzymatic cleavage sites are introduced, where they interact with enzymes conjugated to the detection antibodies within the complex. These probes generate distinct current signatures when translocated through the nanopore after enzymatic cleavage, enabling precise biomarker quantification. This approach offers a low detection limit of up to 0.03 fg ml–1 and the simultaneous detection of six biomarkers, including antigen and antibody biomarkers in blood samples. Overall, the nanopore-based ELISA demonstrates high sensitivity and multiplexing capability, making it suitable for next-generation diagnostic and point-of-care testing applications.